These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 27017136)

  • 21. Breast Cancer Screening Trials: Endpoints and Overdiagnosis.
    Jatoi I; Pinsky PF
    J Natl Cancer Inst; 2021 Sep; 113(9):1131-1135. PubMed ID: 32898241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tomosynthesis in Breast Cancer Imaging: How Does It Fit into Preoperative Evaluation and Surveillance?
    Eghtedari M; Tsai C; Robles J; Blair SL; Ojeda-Fournier H
    Surg Oncol Clin N Am; 2018 Jan; 27(1):33-49. PubMed ID: 29132564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).
    Bernardi D; Houssami N
    Breast; 2017 Apr; 32():98-101. PubMed ID: 28107735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study.
    Ro V; Jones T; Silverman T; McGuinness JE; Guzman A; Amenta J; Kukafka R; Crew KD
    BMC Cancer; 2022 Jul; 22(1):819. PubMed ID: 35897000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of radiomics in breast cancer diagnosis and prognostication.
    Tagliafico AS; Piana M; Schenone D; Lai R; Massone AM; Houssami N
    Breast; 2020 Feb; 49():74-80. PubMed ID: 31739125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing overdiagnosis in mammography screening - a public health perspective.
    Concin H; Nagel G
    Horm Mol Biol Clin Investig; 2017 Dec; 32(1):. PubMed ID: 29252194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.
    Pattacini P; Nitrosi A; Giorgi Rossi P; Iotti V; Ginocchi V; Ravaioli S; Vacondio R; Braglia L; Cavuto S; Campari C;
    Radiology; 2018 Aug; 288(2):375-385. PubMed ID: 29869961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USPSTF Recommendations and Overdiagnosis.
    Hendrick RE; Monticciolo DL
    J Breast Imaging; 2024 Jul; 6(4):338-346. PubMed ID: 38865364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
    Bleyer A
    Acad Radiol; 2015 Aug; 22(8):949-60. PubMed ID: 26100188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Discussion of breast cancer screening model in China].
    Li WQ; Li R; Liu PF; Huang YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1039-43. PubMed ID: 27453120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
    Jung M
    Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial intelligence for breast cancer screening: Opportunity or hype?
    Houssami N; Lee CI; Buist DSM; Tao D
    Breast; 2017 Dec; 36():31-33. PubMed ID: 28938172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital Mammography and Digital Breast Tomosynthesis.
    Moseley TW
    Clin Obstet Gynecol; 2016 Jun; 59(2):362-79. PubMed ID: 27101241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
    van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
    J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis of screen-detected breast cancer.
    Milch V; Aranda S; Canfell K; Varlow M; Roder DM; Currow D; Anderiesz C; Keefe D
    Med J Aust; 2021 Jun; 214(10):455-456.e1. PubMed ID: 33993477
    [No Abstract]   [Full Text] [Related]  

  • 38. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no.
    Bell RJ; Burton RC
    Med J Aust; 2012 Jan; 196(1):17. PubMed ID: 22256918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Richman IB; Gross CP
    Ann Intern Med; 2024 Mar; 177(3):403-404. PubMed ID: 38498894
    [No Abstract]   [Full Text] [Related]  

  • 40. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Zahl PH; Jørgensen KJ
    Ann Intern Med; 2024 Mar; 177(3):403. PubMed ID: 38498895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.